Suven Life Sciences Limited has informed the Exchange regarding a press release dated August 26, 2020, titled "Suven Life Sciences announces five poster presentations including Phase-2 proof-of-concept study design for SUVN-G3031 in patients with narcolepsy at the SLEEP 2020 virtual conference".